Keros Therapeutics Statistics
NASDAQ: KROSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
11.21+0.20 (+1.82%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Keros Therapeutics by the numbers
Keros Therapeutics has a market capitalization of $222.3 million based on 19.83M shares outstanding. With trailing EPS of $-3.22, Keros Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 1.9% above its 50-day average and 12.3% below its 200-day average.
Average daily trading volume is 196.01K shares, or about $2.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
KROS valuation vs. peer median
| Metric | KROS | Peer median | Difference |
|---|---|---|---|
| Market cap | $222.26M | $223.63M | -1% |
| Avg. volume | 196.01K | 490.37K | -60% |
Peer median across 8 companies: TRDA, SION, NATR, EVMN, GLSI, MGNX, LYEL, IFRX.
Valuation
- Market cap
- $222.26M
- EPS (TTM)
- $-3.22
- Shares outstanding
- 19.83M
Price and trading
- Previous close
- 11.01
- Open
- 10.81
- Day range
- 10.81 – 11.32
- 52-week range
- 9.69 – 22.55
- 52-week change
- -28.37%
- Beta
- —
- Volume
- 195.96K
- Average volume
- 196.01K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 222.26M
- Forward Pe
- -1.69
- Eps
- -3.22
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 22.55
- Week52 Low
- 9.69
- Avg Volume
- 196.01K
- Shares Outstanding
- 19.83M
- Ma50
- 11.00
- Ma200
- 12.78
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -50.29%
- Pct From52w Low
- 15.69%